Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

August M&A Analysis: Slow Month Highlighted By Unique Technologies

Executive Summary

The dog-days of summer produced just a handful of mergers and acquisitions in the medtech sector and no blockbuster deals. However, several companies made smaller deals for innovative products in a range of sectors including IVDs, cardiovascular devices, and ophthalmology.


Related Content

Zimmer Biomet Adds CD Diagnostics To List Of 2016 Acquisitions
M&A Analysis: Slow Month Highlighted By A Few Big Deals
Myriad To Enter Neuroscience Market With $225m Assurex Acquisition
IPO Update: Intellia Launch Shows CRISPR Still Excites While Others Struggle
Myriad's myChoice To Be Used In More Cancer Clinical Trials
Medtronic scores sixth M&A deal, while SNN gains and Philips sheds
Arthrex to purchase struggling Cardo’s joint arthroplasty division


Related Companies